178 related articles for article (PubMed ID: 36641426)
1. Metabolic syndrome and its components predict the biochemical recurrence and adverse pathological features of patients following radical prostatectomy: a propensity score matching study.
Liu Z; Zhu X; He J; Lu J
BMC Cancer; 2023 Jan; 23(1):50. PubMed ID: 36641426
[TBL] [Abstract][Full Text] [Related]
2. Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance.
Colicchia M; Morlacco A; Rangel LJ; Carlson RE; Dal Moro F; Karnes RJ
Eur Urol Focus; 2019 May; 5(3):425-432. PubMed ID: 29306730
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
[TBL] [Abstract][Full Text] [Related]
4. MRI-derived tumor volume as a predictor of biochemical recurrence and adverse pathology in patients after radical prostatectomy: a propensity score matching study.
Zhu X; Liu Z; He J; Li Z; He W; Lu J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8853-8861. PubMed ID: 37148292
[TBL] [Abstract][Full Text] [Related]
5. No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis.
Hirasawa Y; Ohori M; Sugihara T; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Yoshioka K; Nakashima J; Tachibana M; Ohno Y
Jpn J Clin Oncol; 2017 Nov; 47(11):1083-1089. PubMed ID: 28973504
[TBL] [Abstract][Full Text] [Related]
6. Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis.
Park JW; Jang WS; Koh DH; Ham WS; Rha KH; Hong SJ; Choi YD
Yonsei Med J; 2018 Jul; 59(5):580-587. PubMed ID: 29869455
[TBL] [Abstract][Full Text] [Related]
7. Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy.
Morlacco A; Dal Moro F; Rangel LJ; Carlson RE; Schulte PJ; Jeffrey KR
Urol Oncol; 2018 Dec; 36(12):528.e1-528.e6. PubMed ID: 30446466
[TBL] [Abstract][Full Text] [Related]
8. Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study.
Byun SS; Lee M; Hong SK; Lee H
PLoS One; 2019; 14(11):e0224671. PubMed ID: 31697718
[TBL] [Abstract][Full Text] [Related]
9. Do Second Primary Cancers Affect the Risk of Biochemical Recurrence in Prostate Cancer Patients Undergoing Radical Prostatectomy? A Propensity Score-Matched Analysis.
Kang M; Jung JW; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
Clin Genitourin Cancer; 2016 Aug; 14(4):e363-9. PubMed ID: 27105723
[TBL] [Abstract][Full Text] [Related]
10. The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy.
Park SG; Shim KH; Choo SH; Kim SJ; Kim SI
Investig Clin Urol; 2021 Jul; 62(4):438-446. PubMed ID: 34085793
[TBL] [Abstract][Full Text] [Related]
11. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of oncologic outcomes for open vs. robot-assisted radical prostatectomy in high-risk prostate cancer.
Lee D; Choi SK; Park J; Shim M; Kim A; Lee S; Song C; Ahn H
Korean J Urol; 2015 Aug; 56(8):572-9. PubMed ID: 26279826
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
[TBL] [Abstract][Full Text] [Related]
14. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
15. Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.
Léon P; Seisen T; Cussenot O; Drouin SJ; Cattarino S; Compérat E; Renard-Penna R; Mozer P; Bitker MO; Rouprêt M
Urol Oncol; 2015 Sep; 33(9):384.e21-7. PubMed ID: 25595576
[TBL] [Abstract][Full Text] [Related]
16. Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.
Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ
Eur Radiol; 2016 Aug; 26(8):2502-9. PubMed ID: 26560721
[TBL] [Abstract][Full Text] [Related]
17. Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients.
Heo JE; Park JS; Lee JS; Kim J; Jang WS; Cho NH; Rha KH; Choi YD; Hong SJ; Ham WS
J Cancer Res Clin Oncol; 2020 Jan; 146(1):221-227. PubMed ID: 31612318
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
Koie T; Mitsuzuka K; Yoneyama T; Narita S; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C; Yoneyama T; Tobisawa Y
Int J Clin Oncol; 2015 Feb; 20(1):176-81. PubMed ID: 24771079
[TBL] [Abstract][Full Text] [Related]
19. Impact of positive surgical margin length and Gleason grade at the margin on biochemical recurrence in patients with organ-confined prostate cancer.
Preisser F; Coxilha G; Heinze A; Oh S; Chun FK; Sauter G; Pompe RS; Huland H; Graefen M; Tilki D
Prostate; 2019 Dec; 79(16):1832-1836. PubMed ID: 31553506
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
